Trovagene to Present at 26th Annual Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 26, 2014 /PRNewswire/ -- Trovagene, Inc. TROV, a developer of cell-free molecular diagnostics, today announced that Chief Executive Officer Antonius Schuh, Ph.D. is scheduled to present a corporate overview at the 26^th Annual Piper Jaffray Healthcare Conference.

Trovagene is scheduled to present at the 26^th Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York, New York on Tuesday, December 2, 2014 at 11:00 a.m. EST. Mr. Schuh will be available for one-on-one meetings during the conference. The presentation will be webcast live at http://www.media-server.com/m/p/3im8baov and can also be accessed through the investor relations page at www.trovagene.com. A replay of the presentation will be available at www.trovagene.com and will be archived for 90 days.

About Trovagene, Inc.

Headquartered in San Diego, California, Trovagene is leveraging its proprietary technology for the detection and monitoring of cell-free DNA in urine. The Company's technology detects and quantitates oncogene mutations in cancer patients for improved disease management. Trovagene's precision cancer monitoring platform is designed to provide important clinical information beyond the current standard of care, and is protected by significant intellectual property including multiple issued patents and pending patent applications globally.

Contact

Logo - http://photos.prnewswire.com/prnh/20120620/LA28014LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trovagene-to-present-at-26th-annual-piper-jaffray-healthcare-conference-300001548.html

SOURCE Trovagene, Inc.